lactobacillus salivarius
Cell therapyexperimental
Ligilactobacillus salivarius is a probiotic bacteria species that has been found to live in the gastrointestinal tract and exert a range of therapeutic properties including suppression of pathogenic bacteria. — Wikipedia
Clinical trial activity
31 trials · 30 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
4
Phase 4
0
Earliest trial started Jan 1, 2002 (NCT00510978)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLigilactobacillus salivarius ↗
- WikipediaLactobacillus salivarius ↗
Also known as
- lactobacillus salivarium
- lactobacillus salivarius bl 3123
- lactobacillus salivarius cect5713
- lactobacillus salivarius hn6
- lactobacillus salivarius ls159
- lactobacillus salivarius ps2
- lactobacillus salivarius ucc118
- lactobacillus salivarius w24
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06166342 | N/A | Sep 15, 2023 | Chia Nan University of Pharmacy and Science, TCI Co., Ltd. |
| NCT05492448 | N/A | Sep 19, 2022 | glac Biotech Co., Ltd. |
| NCT04937556 | N/A | Oct 25, 2021 | ProbiSearch SL |
| NCT05005611 | N/A | May 31, 2021 | Chang Gung University, glac Biotech Co., Ltd. |
| NCT04659408 | N/A | Mar 1, 2021 | Swiss Paraplegic Centre Nottwil |
| NCT05896657 | N/A | Sep 1, 2020 | Biosearch S.A., Universidad Complutense de Madrid |
| NCT06290518 | N/A | Sep 1, 2020 | Biosearch S.A., Universidad Complutense de Madrid |
| NCT04420676 | N/A | Aug 31, 2020 | Medical University of Graz |
| NCT04140604 | N/A | Feb 11, 2020 | glac Biotech Co., Ltd. |
| NCT03993301 | N/A | Jul 20, 2019 | China Medical University, glac Biotech Co., Ltd. |
| NCT03876678 | N/A | Apr 1, 2019 | China Medical University |
| NCT03669094 | N/A | Nov 30, 2018 | ProbiSearch SL, Recordati |
| NCT03614117 | N/A | Oct 31, 2018 | ProbiSearch SL, Recordati |
| NCT04089280 | N/A | Oct 16, 2018 | Sanprobi Sp. z o.o., Silesian University of Medicine |
| NCT04446572 | Phase 2 | Oct 16, 2018 | Biosearch S.A., Centro de Diagnóstico Médico. Ayuntamiento de Madrid., Universidad Complutense de Madrid |
| NCT03801655 | N/A | Aug 15, 2018 | University of Oxford |
| NCT03880760 | N/A | Aug 1, 2018 | China Medical University |
| NCT03449836 | Phase 3 | Mar 1, 2018 | University of Naples Frederico II |
| NCT03334604 | N/A | Feb 16, 2018 | Medical University of Warsaw, Winclove Bio Industries BV |
| NCT03883191 | N/A | Oct 24, 2017 | China Medical University |
Showing 20 of 31 trials
Page 1 / 2
Organizations
Research & Development (30)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Universidad Complutense de Madrid | Academic/Hospital | 6 | 5 | 3 | 2008 |
| China Medical University | Academic/Hospital | 4 | 4 | 1 | 2017 |
| glac Biotech Co., Ltd. | For profit | 4 | 2 | 1 | 2019 |
| Medical University of Graz | Academic/Hospital | 4 | 4 | 1 | 2012 |
| Biosearch S.A. | For profit | 3 | 1 | 2 | 2018 |
| ProbiSearch SL | For profit | 3 | 3 | 1 | 2018 |
| Recordati | For profit | 2 | 0 | 1 | 2018 |
| Austrian Science Fund (FWF) | Government | 1 | 0 | 1 | 2012 |
| Centro de Diagnóstico Médico. Ayuntamiento de Madrid. | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Chang Gung University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Chia Nan University of Pharmacy and Science | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Danone Research | For profit | 1 | 0 | 1 | 2011 |
| European Commission | Government | 1 | 0 | 1 | 2002 |
| Government of Spain | Government | 1 | 0 | 1 | 2011 |
| Hospital Universitario San Cecilio | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Medical University of Warsaw | Academic/Hospital | 1 | 1 | 1 | 2018 |
| National University of Ireland | Academic/Hospital | 1 | 1 | 1 | 2002 |
| Pileje | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Puleva Biotech | For profit | 1 | 1 | 1 | 2006 |
| Sanprobi Sp. z o.o. | For profit | 1 | 0 | 1 | 2018 |
30 organizations
Page 1 / 2